Oral cancer is the cancer where the team and the institutional capability matter most — speech, swallowing, chewing, and appearance all depend on whether the team can remove the tumour and rebuild the area with high-quality reconstruction. CION Cancer Clinics provides multidisciplinary oral cancer care: head and neck surgical oncology, free flap reconstruction through NABH-accredited partners, IMRT chemoradiation, and comprehensive functional rehabilitation — with the same panel and the same tumour board at every centre.
Oral cancer treatment is unique among cancers in how directly it affects daily function. Removing the tumour is only half the job — preserving speech, swallowing, chewing, and appearance depends on whether the team can also rebuild the area with high-quality reconstruction. That is why oral cancer is the cancer where the institutional capability matters most.
CION Cancer Clinics is built around that reality. For oral cancer, CION coordinates head and neck surgical oncology, free flap microvascular reconstruction through NABH-accredited partners, IMRT chemoradiation, immunotherapy where indicated, and a complete functional rehabilitation team — speech therapy, swallowing therapy, dental and prosthodontic specialists, and nutritional support. Every case is reviewed by the CION tumour board before a plan is finalised.
This page explains how oral cancer care at CION is organised, where care is delivered, and what to expect from the first consultation onward. The promise is consistent across every centre: no rushed decisions, no unnecessary tests, transparent costs — and decisions made for healing, not billing.
India accounts for nearly one-third of global oral cancer cases — driven primarily by tobacco chewing (gutka, khaini), betel quid (paan), smoking, and alcohol. The good news: most oral cancers are visible to the eye or felt as palpable lumps inside the mouth, and most are preceded by visible precancerous changes — white patches (leukoplakia), red patches (erythroplakia), or stiffening of the mouth lining (oral submucous fibrosis, closely linked to betel quid use). Regular dental checkups, self-examination, and prompt biopsy of suspicious patches are among the most powerful early-detection strategies available — and significantly improve survival when cancer is caught at the earliest stage. Source: NCCN / WHO Global Cancer Observatory.
A complete, multidisciplinary pathway — from biopsy and staging through surgery, reconstruction, chemoradiation, and long-term functional rehabilitation. Every step is coordinated by the same panel and reviewed by the same tumour board.
Oral cancer diagnosis begins with a tissue biopsy of any suspicious lesion. Staging then uses contrast CT and MRI of the head and neck to measure tumour depth and assess lymph node involvement, with PET-CT for advanced cases to rule out distant spread. For tobacco users, panendoscopy under anaesthesia checks the mouth, throat, voice box, and upper oesophagus because second primary cancers can occur elsewhere in the upper aerodigestive tract. Every case is then reviewed by the CION tumour board, which assigns a TNM stage and produces a written plan — yours to keep.
Where a case requires wide local excision, selective or modified radical neck dissection, segmental or marginal mandibulectomy, or maxillectomy, CION coordinates the procedure through NABH-accredited partner hospitals with established head and neck cancer surgery programs. The most important capability is free flap microvascular reconstruction — tissue taken from the forearm, leg, or thigh along with its blood supply and transplanted to rebuild the area where the tumour was removed, with the blood vessels reconnected to vessels in the neck under a microscope. Without high-quality reconstruction, speech, swallowing, and chewing are significantly compromised.
Oral cancer treatment often involves a six-to-seven-week course of daily radiation, typically given as intensity-modulated radiation (IMRT) that precisely targets the tumour while sparing the salivary glands and other healthy tissues. Concurrent cisplatin chemotherapy — given alongside radiation — is the standard for locally advanced cases or as definitive treatment when surgery is not chosen; cetuximab is an alternative for patients unfit for cisplatin. Because daily radiation visits over many weeks add up, CION delivers day-care chemoradiation across its network so treatment stays close to home.
For recurrent or metastatic oral cancer, immunotherapy drugs — pembrolizumab and nivolumab — are part of the standard pathway, particularly for PD-L1-positive tumours, and are administered with on-site oncologist supervision. Induction chemotherapy with the TPF combination (docetaxel, cisplatin, and 5-FU) is used in selected locally advanced cases. Every drug choice is made by the tumour board based on stage, biomarkers, and the patient's overall fitness — not on a single doctor's opinion, and never with unnecessary tests.
Oral cancer survivors face permanent changes to speech, swallowing, chewing, and appearance — and the quality of functional rehabilitation directly determines quality of life. CION coordinates speech therapy, swallowing therapy, dental rehabilitation (extractions before radiation, implants afterwards), prosthodontic rehabilitation including obturators for palate defects, nutritional support (often a feeding tube during the most intense weeks of chemoradiation), jaw exercises for trismus, and management of dry mouth from radiation damage to the salivary glands. Tobacco and betel quid cessation counselling is integrated throughout, because tobacco users carry a high risk of second primary cancers.
Every oral cancer case at CION is reviewed by the multidisciplinary tumour board before the treatment plan is finalised. The board debates the TNM stage, the surgical approach including the extent of resection and the type of neck dissection, the reconstruction plan, adjuvant radiation or chemoradiation decisions, and functional rehabilitation. It produces a written summary that becomes part of your records — and yours to keep for any second opinion, anywhere. CION offers a free 45-minute consultation and written second opinion: bring your biopsy and scans, with no commitment to start treatment.
Surveillance examinations, day-care chemotherapy and immunotherapy, speech and swallowing therapy, nutritional follow-up, and dental reviews happen at the centre nearest you. Complex head and neck surgery, free flap reconstruction, IMRT chemoradiation, and brachytherapy run through NABH-accredited partners with verified surgical expertise. Same panel, same protocols, same tumour board at every site.
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
AIIMS-led surgical oncology, with reconstruction planning from the first consultation. Medical and radiation oncologists across the network — same panel, same tumour board, every centre.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
Bring your biopsy and scans. Get a written second opinion with tumour-board review and reconstruction planning — free, and yours to keep. Decisions for healing, not billing.
Specifics beat vague claims. Here is the verifiable network footprint behind oral cancer care at CION Cancer Clinics.
| Network metric | CION figure |
|---|---|
| Centres across Telangana & Andhra Pradesh | 35+ |
| Super-specialist oncologists on panel | 17 |
| Combined clinical experience | 150+ years |
| Patients treated successfully | 15,000+ |
| Google review rating | 4.8★/5 |
| Oral cancer 1-year survival (CION)* | 80.0% |
| Oral cancer 1-year survival (national average)* | 71.6% |
| Every consultation | 45 minutes |
| Head & neck surgery & free flap reconstruction partners | NABH-accredited |
| Tumour-board review on every case (with reconstruction planning) | Yes — written summary |
| Functional rehabilitation (speech, swallowing, dental, prosthodontics) | Integrated pathway |
| Written second opinion | Free (worth ₹950) |
| Insurance and ArogyaSri accepted | Yes — empanelled |
| EMI facility for self-paying patients | Available on selected packages |
*1-year survival rates. CION 80.0% vs national average 71.6%. Source: ICMR / NCRP, cited in the page footer. Survival statistics are population-level estimates and do not predict outcomes for an individual case.
Medical Disclaimer: The information on this page is provided for general educational purposes and reflects current clinical practice in oral cancer oncology at the time of last medical review. It is not a substitute for individual medical advice, diagnosis, or treatment. Treatment decisions, drug choices, dosing, surgical approach, and follow-up schedules must be made by a qualified physician evaluating the specific patient. Survival statistics cited are population-level estimates drawn from public registries and do not predict outcomes for an individual case. Always discuss your specific situation with a qualified medical or surgical oncologist before acting on any information presented here.
Last Medically Reviewed: June 2026 by Dr. Muralidhar Muddusetty — Surgical Oncologist, MBBS (AIIMS), MS Surgery (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh).
Oral cancer care is a long journey of speech, swallowing, and recovery. See how CION's tumour-board approach and reconstruction planning helped patients return to daily life.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.CION Cancer Clinics provides multidisciplinary oral cancer care — biopsy and detailed imaging, tumour-board review with TNM staging, head and neck surgery with free flap reconstruction through NABH-accredited partners, IMRT chemoradiation, immunotherapy where indicated, and comprehensive functional rehabilitation (speech, swallowing, dental, and prosthodontic care). Care is delivered across a network of centres in Hyderabad with the same panel of oncologists, the same NCCN protocols, and the same tumour board at every site.
CION runs a multi-centre network across Hyderabad with 35+ centres across Telangana and Andhra Pradesh. Surveillance examinations, day-care chemotherapy and immunotherapy, speech and swallowing therapy, nutritional follow-up, and dental reviews happen at the centre nearest you. Complex head and neck surgery, free flap reconstruction, IMRT chemoradiation, and brachytherapy run through NABH-accredited partners with verified surgical expertise. You can pick the closest centre and call directly, or let the team help you choose.
Oral cancer at CION is managed by a multidisciplinary team built around a head and neck surgical oncologist — a surgeon specifically trained in head and neck cancers — together with a medical oncologist, a radiation oncologist trained in IMRT, a microvascular reconstructive surgeon for free flap reconstruction, and a functional rehabilitation team (speech therapy, swallowing therapy, dental and prosthodontic specialists, nutrition). Every case is reviewed by the CION tumour board before the treatment plan is finalised, so decisions come from a team, not a single doctor.
Outcomes depend strongly on the stage at diagnosis. CION reports a 1-year survival rate of 80.0% for oral cancer, against a national average of 71.6%* — survival improves significantly when cancer is caught at the earliest stage and treated with high-quality surgery and reconstruction. Survival statistics are population-level estimates and do not predict outcomes for an individual case. *1-year survival; source cited in the page footer (ICMR / NCRP).
Yes. Free flap microvascular reconstruction — where tissue is taken from the forearm, leg, or thigh along with its blood supply and transplanted to rebuild the area where the tumour was removed, with the blood vessels reconnected to vessels in the neck under a microscope — is coordinated through NABH-accredited partner hospitals with trained microvascular reconstructive surgeons. This is the most important functional capability for oral cancer: without high-quality reconstruction, swallowing, speech, and chewing are significantly compromised after major tumour removal.
Yes. CION offers a free 45-minute consultation with a senior oncologist and a written second opinion with tumour-board review and reconstruction planning — yours to keep. Bring your biopsy report and scans. There is no commitment to start treatment, and the written summary can be taken to any other hospital for a further opinion. Decisions for healing, not billing.
CION is empanelled for ArogyaSri and accepts most major cashless insurance providers and TPAs, with pre-authorisation handled by the CION insurance desk. An EMI facility is available for self-paying patients on selected packages. Empanelment can vary by centre and by procedure — free flap reconstruction and immunotherapy in particular have specific scheme rules — so request a written, itemised cost estimate and confirm pre-authorisation before treatment begins.
You can book a free consultation by submitting the form on this page, or call CION directly on 1800-202-8726. The consultation is a 45-minute detailed session with a senior oncologist and includes a free written second opinion. The team will help you pick the centre nearest you and guide your next steps with clear, transparent costs — no unnecessary tests.